Is Wellbutrin (bupropion) used to treat alcoholism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion (Wellbutrin) is Not Recommended for Treating Alcoholism

Bupropion (Wellbutrin) is not recommended for the treatment of alcoholism, as it is not FDA-approved for this indication and current guidelines do not support its use for alcohol use disorder. 1

Evidence-Based Treatments for Alcohol Use Disorder

Current guidelines recommend several first-line pharmacological interventions for alcohol use disorder:

FDA-Approved Medications

  • Baclofen: High efficacy in patients with cirrhosis and no hepatotoxicity risk 1
  • Naltrexone: Reduces relapse by approximately 29% (caution with liver disease) 1
  • Acamprosate: Effective for maintaining abstinence after detoxification 2, 1
  • Gabapentin: Promising option for patients with impaired liver function 1

Acute Withdrawal Management

  • Benzodiazepines: First-line treatment for alcohol withdrawal syndrome 2
    • Long-acting benzodiazepines (chlordiazepoxide, diazepam) for prevention of seizures
    • Lorazepam for patients with severe AWS, advanced age, liver failure, or other serious conditions
  • Thiamine supplementation: 100-300 mg/day to prevent Wernicke encephalopathy 2, 1

Bupropion and Alcoholism: Research Findings

While bupropion is not indicated for alcoholism treatment, some relevant research exists:

  • A 2019 preclinical study showed bupropion reduced ethanol intake in mice, alone and in combination with naltrexone 3, but this has not translated to clinical recommendations.

  • Bupropion has been studied in alcoholics primarily for smoking cessation, not for treating the alcohol use disorder itself 4, 5.

  • There are concerns about bupropion's pharmacokinetics in alcoholic liver disease, with prolonged elimination half-life of its metabolites 6.

  • A case report documented unexpected aggressive behavior with bupropion and alcohol interaction 7, raising safety concerns.

Comprehensive Treatment Approach for Alcoholism

For effective management of alcohol use disorder:

  1. Complete alcohol abstinence is the most important treatment goal 2, 1

  2. Pharmacotherapy options (in order of recommendation):

    • Baclofen for patients with liver disease
    • Naltrexone for patients with normal liver function
    • Acamprosate for maintenance after detoxification
  3. Psychosocial interventions:

    • Cognitive Behavioral Therapy (CBT)
    • Support groups (e.g., Alcoholics Anonymous)
    • Brief interventions using the FRAMES model
    • Contingency management 1

Important Considerations and Pitfalls

  • Do not use disulfiram in patients with liver disease due to high hepatotoxicity risk 1

  • Monitor liver function regularly, especially with medications like naltrexone 1

  • Psychiatric consultation is recommended for evaluation, treatment, and long-term planning of alcohol abstinence 2

  • Bupropion should not be combined with alcohol due to potential adverse interactions, including aggressive behavior 7

  • Thiamine supplementation is essential for all patients with alcohol use disorder to prevent neurological complications 2, 1

In conclusion, while bupropion has established efficacy for depression and smoking cessation, it is not a recommended treatment for alcoholism. Clinicians should instead utilize evidence-based medications like baclofen, naltrexone, or acamprosate in combination with psychosocial interventions to achieve the best outcomes for patients with alcohol use disorder.

References

Guideline

Sleep Management and Liver Disease Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.

The British journal of psychiatry : the journal of mental science, 1999

Research

Unexpected aggressive behaviour: interaction of bupropion and alcohol.

The International journal of risk & safety in medicine, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.